Home > Insider Trading > Filing (0001138723-20-000113)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	208370041

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1159917	Joshua Levine	1310 Chesapeake Terrace Sunnyvale CA 94089	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-30	280,269	$0.00	1,045,212	No	4	A	Direct
Common Stock	Disposition	2020-12-02	15,674	$4.07	1,029,538	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2020-11-30	527,426	$0.00	527,426	$4.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
527,426		2030-11-30	No	4	A	Direct

Footnotes

Fiscal year 2021 Performance award with two Performance Measurement Periods The first represents 40% of the grant and is from 7/1/2020 to 6/30/2021. The second represents 60% and is from 7/1/2021 to 06/30/2022. If the metrics are met for the first performance period vesting will commence quarterly beginning 9/30/2021 and ending 06/30/2023. If the metrics are met for the second performance period vesting will commence quarterly beginning 09/30/2022 and ending 06/30/2023.
Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
25% of the shares subject to such Option shall vest and be exercisable on the one-year anniversary of the Grant Date and an additional 1/48th of the original number of shares subject to such Option shall vest on the corresponding date of each month thereafter, subject to the applicable Grantee continuing to be a service provider through each such date.